Balaji Life Sciences Private Limited
Pharmaceutical company specializing in manufacturing, trading, and exporting medical drugs and supplies.
2003 | Delhi (India) | Merged
Balaji Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -99.90%
- Profit Growth -99.71%
- Ebitda 100.00%
- Net Worth -99.90%
- Total Assets -99.90%
About Balaji Life Sciences
Balaji Life Sciences Private Limited (BLSPL) is Amalgamated company established on 06 Nov 2003 with its office registered at Delhi, India and has been running since 21 Year, 3 Months with a paid up capital of 0.75 M. According to MCA records, 2 Directors are linked to this company as of 16 Jan 2025.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL2003PTC122966
- Company No.
122966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Balaji Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunita Mittal  | Director | 06-Nov-2003 | Current |
| Vinod Mittal | Director | 06-Nov-2003 | Current |
Financial Performance of Balaji Life Sciences.
Balaji Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.9% decrease. The company also saw a substantial fall in profitability, with a 99.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Balaji Life Sciences?
In 2021, Balaji Life Sciences had a promoter holding of 87.07% and a public holding of 12.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indo-Bhutan Construction Solutions Private LimitedVinod Mittal is a mutual person
- Innovative Infracity Private Limited
Sunita Mittal is a mutual person
- Vsm Housing Private Limited
Sunita Mittal is a mutual person
- Luhari Warehousing And Logistics Park Private Limited
Sunita Mittal is a mutual person
- Balaji Assets Reconstruction Company Limited
Sunita Mittal and Vinod Mittal are mutual person
- Vsm Food Cold Chain And Processors Llp
Vinod Mittal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Balaji Life Sciences?
Unlock and access historical data on people associated with Balaji Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balaji Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balaji Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.